Cotrimoxazole reduces systemic inflammation in HIV infection by altering the gut microbiome and immune activation.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
03 04 2019
Historique:
received: 09 08 2018
revised: 21 11 2018
accepted: 14 02 2019
entrez: 5 4 2019
pubmed: 5 4 2019
medline: 6 5 2020
Statut: ppublish

Résumé

Long-term cotrimoxazole prophylaxis reduces mortality and morbidity in HIV infection, but the mechanisms underlying these clinical benefits are unclear. Here, we investigate the impact of cotrimoxazole on systemic inflammation, an independent driver of HIV mortality. In HIV-positive Ugandan and Zimbabwean children receiving antiretroviral therapy, we show that plasma inflammatory markers were lower after randomization to continue (

Identifiants

pubmed: 30944164
pii: 11/486/eaav0537
doi: 10.1126/scitranslmed.aav0537
pmc: PMC6783302
mid: EMS84494
pii:
doi:

Substances chimiques

Cytokines 0
Inflammation Mediators 0
Trimethoprim, Sulfamethoxazole Drug Combination 8064-90-2

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 206225
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0300400
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1001190
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 206225/Z/17/Z
Pays : United Kingdom
Organisme : CIHR
Pays : Canada
Organisme : Wellcome Trust
ID : 093768
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U122886353
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12023/17
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 108065/Z/15/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_EX_G0300400
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12023/26
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 093768/Z/10/Z
Pays : United Kingdom
Organisme : CIHR
ID : G0300400
Pays : Canada
Organisme : Wellcome Trust
ID : 108065
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

PLoS Pathog. 2016 Jan 14;12(1):e1005384
pubmed: 26764484
Nat Med. 2006 Dec;12(12):1365-71
pubmed: 17115046
Clin Exp Immunol. 1992 Apr;88(1):23-8
pubmed: 1563105
PLoS Comput Biol. 2012;8(6):e1002358
pubmed: 22719234
N Engl J Med. 2018 Apr 26;378(17):1583-1592
pubmed: 29694816
Can Med Assoc J. 1975 Jun 14;112(13 Spec No):76-9
pubmed: 1079471
PLoS Med. 2008 Oct 21;5(10):e203
pubmed: 18942885
J Clin Invest. 2012 Jan;122(1):62-9
pubmed: 22156200
AIDS. 2015 Jan 2;29(1):43-51
pubmed: 25387317
J Infect Dis. 2016 Jul 15;214(2):226-36
pubmed: 27190179
Immunology. 2005 Aug;115(4):565-74
pubmed: 16011525
J Infect Dis. 2016 Oct 1;214 Suppl 2:S44-50
pubmed: 27625430
Br Med J. 1972 Jul 15;3(5819):144-6
pubmed: 5039776
J Infect Dis. 2011 Mar 15;203(6):780-90
pubmed: 21252259
J Microbiol Biotechnol. 2015 Jul;25(7):1136-45
pubmed: 25737115
JAMA. 2012 Jul 25;308(4):353-61
pubmed: 22820788
J Infect Dis. 2013 Aug 15;208(4):653-61
pubmed: 23687226
J Infect Dis. 2014 Mar 1;209(5):739-48
pubmed: 24133185
PLoS One. 2014 Feb 26;9(2):e89943
pubmed: 24587140
J Acquir Immune Defic Syndr. 2015 Apr 1;68(4):396-404
pubmed: 25514794
Antimicrob Agents Chemother. 1995 Jan;39(1):28-33
pubmed: 7695325
Lancet. 2013 Apr 20;381(9875):1391-1403
pubmed: 23473847
Cell Host Microbe. 2016 Mar 9;19(3):311-22
pubmed: 26962942
PLoS One. 2013 Dec 30;8(12):e83418
pubmed: 24386196
AIDS Res Hum Retroviruses. 2015 Aug;31(8):830-6
pubmed: 26059763
J Infect Dis. 1999 Apr;179(4):859-70
pubmed: 10068581
Cell Host Microbe. 2013 Sep 11;14(3):329-39
pubmed: 24034618
Emerg Infect Dis. 2002 Jan;8(1):92-3
pubmed: 11749759
PLoS Negl Trop Dis. 2018 Jan 19;12(1):e0006205
pubmed: 29351288
J Exp Med. 2004 Sep 20;200(6):749-59
pubmed: 15365096
Immunol Cell Biol. 2010 Mar-Apr;88(3):321-7
pubmed: 20065992
J Clin Microbiol. 2010 Nov;48(11):3829-35
pubmed: 20810781
Lancet. 2010 Apr 10;375(9722):1278-86
pubmed: 20347483
Nat Methods. 2016 May;13(5):435-8
pubmed: 26999001
Nucleic Acids Res. 2014 Jan;42(Database issue):D222-30
pubmed: 24288371
Lancet Infect Dis. 2015 Mar;15(3):327-39
pubmed: 25618179
Nature. 1970 Jul 25;227(5256):393-4
pubmed: 4913712
PLoS One. 2011;6(7):e21843
pubmed: 21765919
EBioMedicine. 2018 Apr;30:192-202
pubmed: 29650491
Nat Methods. 2015 Oct;12(10):902-3
pubmed: 26418763
Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):431-6
pubmed: 15625114
PLoS One. 2011 Apr 06;6(4):e18688
pubmed: 21494695
J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Oct 1;16(2):83-92
pubmed: 9358102
PLoS One. 2013;8(1):e55038
pubmed: 23383047
Pediatr Infect Dis J. 2015 Feb;34(2):e23-31
pubmed: 25068287
Biochem Soc Trans. 1997 May;25(2):253S
pubmed: 9191297
BMJ. 2014 Apr 15;348:g2267
pubmed: 24735883
Mucosal Immunol. 2014 Jul;7(4):983-94
pubmed: 24399150
Antimicrob Agents Chemother. 1980 Mar;17(3):322-6
pubmed: 7425598
PLoS One. 2014 Dec 05;9(12):e114277
pubmed: 25479553
J Int AIDS Soc. 2017 Nov;20(3):
pubmed: 29119726
PLoS One. 2014 Feb 18;9(2):e86928
pubmed: 24558364
J Leukoc Biol. 1994 Jun;55(6):749-55
pubmed: 8195701
Clin Infect Dis. 2011 Apr 1;52(7):953-6
pubmed: 21427404
N Engl J Med. 2014 Jan 2;370(1):41-53
pubmed: 24382064
Nat Med. 2018 Sep;24(9):1313-1316
pubmed: 30061696
Microbiology. 2012 Jun;158(Pt 6):1389-401
pubmed: 22466083
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8489-E8498
pubmed: 30126990
Blood. 2004 Dec 1;104(12):3513-9
pubmed: 15297312
HIV Med. 2015 Jan;16(1):48-56
pubmed: 24889179

Auteurs

Claire D Bourke (CD)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK. c.bourke@qmul.ac.uk.

Ethan K Gough (EK)

School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Godfrey Pimundu (G)

Joint Clinical Research Centre, Kampala, Uganda.

Annie Shonhai (A)

College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Chipo Berejena (C)

College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Louise Terry (L)

Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.

Lucas Baumard (L)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK.

Naheed Choudhry (N)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK.

Yusuf Karmali (Y)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK.

Mutsa Bwakura-Dangarembizi (M)

College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Victor Musiime (V)

Joint Clinical Research Centre, Kampala, Uganda.
College of Health Sciences, Department of Paediatrics and Child Health, Makerere University, Kampala, Uganda.

Joseph Lutaakome (J)

Uganda Virus Research Institute/MRC Uganda Research Unit on AIDS, Entebbe, Uganda.

Adeodata Kekitiinwa (A)

Baylor College of Medicine Children's Foundation-Uganda, Mulago Hospital, Kampala, Uganda.

Kuda Mutasa (K)

Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.

Alexander J Szubert (AJ)

MRC Clinical Trials Unit at University College London, London WC1V 6LJ, UK.

Moira J Spyer (MJ)

MRC Clinical Trials Unit at University College London, London WC1V 6LJ, UK.

Jane R Deayton (JR)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK.
Royal London Hospital, Barts Health NHS Trust, London E1 1BB, UK.

Magdalena Glass (M)

School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Hyun Min Geum (HM)

School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Claire Pardieu (C)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK.

Diana M Gibb (DM)

MRC Clinical Trials Unit at University College London, London WC1V 6LJ, UK.

Nigel Klein (N)

UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.

Thaddeus J Edens (TJ)

Devil's Staircase Consulting, West Vancouver, British Columbia V7T 1V7, Canada.

A Sarah Walker (AS)

MRC Clinical Trials Unit at University College London, London WC1V 6LJ, UK.

Amee R Manges (AR)

School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Andrew J Prendergast (AJ)

Blizard Institute, Queen Mary University of London, London E1 2AT, UK.
Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
MRC Clinical Trials Unit at University College London, London WC1V 6LJ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH